symbol CRL
会社名 Charles River Laboratories International Inc. (CHRLS RIVER LABS)
業種 バイオテクノロジ―_メディカルリサ―チ   医療関連(Health Care)
概要 チャールズ・リバー・ラボラトリーズ・インターナショナル(Charles River Laboratories International Inc.)は初期段階の創薬と開発プロセスを促進するソリューションを提供する。同社は生体内生物学を中心に事業を展開する。同社のポートフォリオは生体内薬物の発見と開発を支援する研究モデル・サービスを含む。同社は研究モデル・サービス(RMS)区分及び前臨床サービス(PCS)区分の2事業区分を通して運営する。同社はRMS区分を通して、薬剤開発業界向けに研究モデルを提供している。同社は遺伝学的と微生物学的に定義された目的に繁殖されたラット及びマウスを主とする齧歯類の研究モデル系統の生産と販売に従事する。PCS事業区分は依頼人向けに、規制を必要とする安全性評価と関連薬剤開発業務のアウトソーシングサービスを提供する。平成24年8月、同社はAccugenix Incを買収した。平成25年1月、同社はVital Riverの持分の75%を取得した。  チャ―ルズ・リバ―・ラボラトリ―ズ・インタ―ナショナルは、迅速で効率的な新薬創出の実現をサポ―ト。新薬の研究開発から承認までのプロセスに必要な標的探索から臨床試験まで一括提供。事業は研究サ―ビスと前臨床サ―ビスの2部門。サ―ビスは、受託試験、受託飼育、医薬品、化学品、農薬等の受託サ―ビスなど。また、実験動物、研究試薬を生産、販売する。  Charles River Laboratories International, Inc. is an early-stage contract research company, which provides essential products and services to help pharmaceutical and biotechnology companies, government agencies and academic institutions. It operates through the following segments: Research Models & Services, Discovery & Safety Assessment and Manufacturing Support. The Research Models & Services segment comprises of the production and sale of research models, and also offers services designed to support its client’s use of research models in screening non-clinical drug candidates. The Discovery & Safety Assessment segment offers discovery and safety assessment services, both regulated and non-regulated, in which it include both in vivo and in vitro studies, supporting laboratory services, and strategic preclinical consulting and program management to support product development. The Manufacturing Support segment provides endotoxin and microbial detection, avian vaccine and biologics testing solutions. The company was founded by Henry L. Foster in 1947 and is headquartered in Wilmington, MA.
本社所在地 251 Ballardvale Street Wilmington MA 01887 USA
代表者氏名 James C. Foster
代表者役職名 Chairman of the Board President Chief Executive Officer
電話番号 +1 781-222-6000
設立年月日 1994年
市場名 NYSE(ニューヨーク証券取引所)
従業員数 14700人
EBITDA (百万ドル) 519.91300
時価総額 (百万ドル) 6939.76800
売上高 (百万ドル) 2266.09600
企業価値(EV) (百万ドル) 8411.45500
当期純利益 (百万ドル) 219.36700
決算概要 BRIEF: For the fiscal year ended 29 December 2018 Charles River Laboratories Intl. Inc revenues increased 22% to $2.27B. Net income before extraordinary items increased 9% to $219.4M. Revenues reflect Discovery And Safety Assessment segment increase of 34% to $1.32B Manufacturing Support segment increase of 12% to $429.6M Research Models segment increase of 5% to $519.7M United States segment increase of 32% to $1.27B.



   Viral Inactivation Market 2020 Segment Analysis By Danaher, Merck KGaA, PARKER HANNIFIN CORP, Sartorius AG, SGS SA, Charles River  2020/10/05 13:00:45 OpenPR
Global viral inactivation market is registering a healthy CAGR of 12.97% in the forecast period of 2019-2026. This rise in the market value can be attributed to the surging R&D innovation, and drug discoveries and increasing government support for the
   Charles River Launches Wealth Hub Utility to Streamline Sponsor/Manager Communication  2020/10/05 13:00:00 Business Wire
BOSTON--(BUSINESS WIRE)-- #FixedIncome--Charles River Wealth Hub connects managed account program sponsors and their asset manager distribution partners through a secure network environment.
   Healthcare Analytical Testing Services Market Worth USD 8.4 Billion by 2025 - Leading Companies are Eurofins Scientific (Luxembourg), LabCorp (US), SGS (Switzerland), Charles River Laboratories (US), WuXi PharmaTech (China)  2020/10/05 09:13:16 OpenPR
According to the new market research report "Healthcare Analytical Testing Services Market by Type (Method Development & Validation, Cell-Based Assays, Stability Testing, Heavy Metal Testing, Image Analysis, Virology Testing) & End user (Pharmaceuticals, Medical Devices) - Global Forecast to 2025",
   Why Outsourced Drug Discovery Market May Turn As Winner After Covid-19 Scenario? In Globally With Quintiles, Charles River Laboratories, Aptuit, Evotec, Genscript, PPD, Wuxi Apptec, AMRI  2020/10/03 06:34:30 OpenPR
Drug discovery is the process through which potential new medicines are identified. It involves a wide range of scientific disciplines, including biology, chemistry, and pharmacology. Report Consultant has recently added a new survey report Outsourced Drug Discovery Market to its
   Drug Discovery Services Market to Watch: Spotlight on Charles River Laboratories, Thermo Fisher Scientific, Merck  2020/09/30 14:24:41 OpenPR
A new business intelligence report released by HTF MI with title "COVID-19 Outbreak-Global Drug Discovery Services Industry Market Report-Development Trends, Threats, Opportunities and Competitive Landscape in 2020" is designed covering micro level of analysis by manufacturers and key business segments.
   Charles River Laboratories: Strong Results But Not Out Of The Woods Just Yet (NYSE:CRL)  2020/08/16 20:34:38 Seeking Alpha
Charles River reported Q2 2020 results that beat the top and bottom line estimates. However, the company's research business contended with strong headwinds again this quarter.
   Charles River Laboratories International : Q2 2020 Earnings Presentation | MarketScreener  2020/08/05 11:22:11 MarketScreener
2Q 2020 Results August 5, 2020 Charles River Laboratories … | August 5, 2020
   Comet Resources Quarterly Activities Report – June 2020  2020/07/30 14:00:31 Investing News Network
Comet Resources Ltd (Comet or the Company) (ASX:CRL) is pleased announce the Quarterly Activities Report and Appendix 5B for the quarter ending 30 June 2020. The post Comet Resources Quarterly Activities Report – June 2020 appeared first on Investing News Network .
   COVID-19 Impact & Recovery Analysis | Healthcare Analytical Testing Services Market 2020-2024 | Evolving Opportunities with Almac Group Ltd. and Charles River Laboratories International Inc. | Technavio  2020/07/29 10:30:00 Business Wire
The Global Healthcare Analytical Testing Services Market will grow by $ 3.98 bn during 2020-2024
   TPT Retirement Solutions Selects Charles River for Portfolio Management and Risk  2020/07/28 10:30:00 Business Wire
TPT Retirement Solutions will use Charles River IMS and Charles River IBOR to manage its 350,000 scheme members' pensions.

 関連キーワード  (バイオテクノロジ―_メディカルリサ―チ 米国株 CHRLS RIVER LABS CRL )

 twitter  (公式ツイッターやCEOツイッターなど)